{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:39:45Z","timestamp":1791225585798,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.colsurfb.2012.01.021","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T20:03:23Z","timestamp":1327953803000},"page":"101-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Polymeric particles for the controlled release of human amylin"],"prefix":"10.1016","volume":"94","author":[{"given":"Luiz Henrique","family":"Guerreiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ricci-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendell","family":"Girard-Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camile Moreira","family":"Mascarenhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Sola-Penna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kildare","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Maur\u00edcio T.R.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.colsurfb.2012.01.021_bib0005","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.84.23.8628","article-title":"Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients","volume":"84","author":"Cooper","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0010","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(87)91444-9","article-title":"Diabetes-associated peptide","volume":"2","author":"Cooper","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0015","first-page":"414","article-title":"Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone","volume":"127","author":"Westermark","year":"1987","journal-title":"Am. J Pathol."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0020","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1073\/pnas.84.11.3881","article-title":"Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells","volume":"84","author":"Westermark","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0025","first-page":"124","article-title":"A is for amylin and amyloid in type 2 diabetes mellitus","volume":"2","author":"Hayden","year":"2001","journal-title":"J. Pancreas"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0030","series-title":"Amylin: Physiology and Pharmacology","author":"Young","year":"2005"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0035","series-title":"Handbook of Physiology","article-title":"Amylin and related proteins: physiology and pathophysiology","author":"Cooper","year":"2001"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0040","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0006-291X(91)90628-K","article-title":"Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets","volume":"177","author":"Broderick","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00401050","article-title":"Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man","volume":"33","author":"Bretherton-Watt","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0050","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1677\/joe.0.124R009","article-title":"Amylin and amylin-amide lack an acute effect on blood glucose and insulin","volume":"124","author":"Ghatei","year":"1990","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s001250050088","article-title":"Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans","volume":"37","author":"Wilding","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0060","first-page":"1032","article-title":"Very high concentrations of islet amyloid polypeptide are necessary to alter the insulin response to intravenous glucose in man","volume":"74","author":"Bretherton-Watt","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0065","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1054-3589(05)52018-0","article-title":"Clinical studies","volume":"52","author":"Young","year":"2005","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0070","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1073\/pnas.87.13.5036","article-title":"Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2299(199604)37:4<231::AID-DDR5>3.0.CO;2-M","article-title":"Preclinical pharmacology of pramlintide in the rat: comparisons with human and rat amylin","volume":"37","author":"Young","year":"1996","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0080","first-page":"203","article-title":"Review of pramlintide as adjunctive therapy in treatment of type 1 and type 2 diabetes","volume":"2","author":"Ryan","year":"2009","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0085","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/ncpendmet0506","article-title":"Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes?","volume":"3","author":"Edelman","year":"2007","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0090","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2147\/vhrm.2006.2.3.203","article-title":"Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes","volume":"2","author":"Pullman","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0095","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1345\/aph.1M210","article-title":"The role of pramlintide for weight loss","volume":"44","author":"Dunican","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0100","doi-asserted-by":"crossref","first-page":"179674","DOI":"10.1155\/2011\/179674","article-title":"Pharmacotherapies for obesity: past, current, and future therapies","volume":"2011","author":"Ioannides-Demos","year":"2011","journal-title":"J. Obes."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0105","doi-asserted-by":"crossref","first-page":"11982","DOI":"10.1074\/jbc.M809085200","article-title":"Dynamic alpha-helix structure of micelle-bound human amylin","volume":"284","author":"Patil","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0110","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1021\/ja9010095","article-title":"Three-dimensional structure and orientation of rat islet amyloid polypeptide protein in a membrane environment by solution NMR spectroscopy","volume":"131","author":"Nanga","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0115","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1529\/biophysj.108.136226","article-title":"Peptide aggregation in finite systems","volume":"95","author":"Singh","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0120","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jmb.2003.10.045","article-title":"The mechanism of insulin action on islet amyloid polypeptide fiber formation","volume":"335","author":"Larson","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0125","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1110\/ps.036350.108","article-title":"Interaction of membrane-bound islet amyloid polypeptide with soluble and crystalline insulin","volume":"17","author":"Knight","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0130","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/pro.145","article-title":"Atomic structures of IAPP (amylin) fusions suggest a mechanism for fibrillation and the role of insulin in the process","volume":"18","author":"Wiltzius","year":"2009","journal-title":"Protein Sci."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0135","doi-asserted-by":"crossref","first-page":"9900","DOI":"10.1021\/bi800828u","article-title":"Amylin proprotein processing generates progressively more amyloidogenic peptides that initially sample the helical state","volume":"47","author":"Yonemoto","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0140","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1021\/la902980d","article-title":"Inhibition of IAPP and IAPP(20-29) fibrillation by polymeric nanoparticles","volume":"26","author":"Cabaleiro-Lago","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0939-6411(97)00056-8","article-title":"Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres","volume":"43","author":"Blanco","year":"1997","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0150","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0168-3659(01)00397-2","article-title":"Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA","volume":"75","author":"Perez","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0155","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.178.4063.871","article-title":"Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range","volume":"178","author":"Udenfriend","year":"1972","journal-title":"Science"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0160","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1002\/pro.5560041120","article-title":"How to measure and predict the molar absorption coefficient of a protein","volume":"4","author":"Pace","year":"1995","journal-title":"Protein Sci."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0165","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/hc0202.101988","article-title":"In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits","volume":"105","author":"Jiao","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-8227(92)90142-E","article-title":"Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse","volume":"18","author":"Panagiotidis","year":"1992","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0175","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.colsurfb.2010.07.008","article-title":"Microcapsules of alginate\/chitosan containing magnetic nanoparticles for controlled release of insulin","volume":"81","author":"Finotelli","year":"2010","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0180","unstructured":"L.H. Guerreiro, D. Da Silva, M. Sola-Penna, D.M. Mizurini, L.M.T.R. Lima, 2012. unpublished work."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0185","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1242\/dmm.006239","article-title":"Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice","volume":"3","author":"Ayala","year":"2010","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0190","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/jps.2600581021","article-title":"Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules","volume":"58","author":"Wagner","year":"1969","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-4889(92)90260-I","article-title":"Amylin inhibits insulin-stimulated glucose uptake in C2C12 muscle cell line through a cholera-toxin-sensitive mechanism","volume":"1136","author":"Sheriff","year":"1992","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0200","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.2001.16.5.958","article-title":"Amylin and bone metabolism in streptozotocin-induced diabetic rats","volume":"16","author":"Horcajada-Molteni","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.colsurfb.2012.01.021_bib0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0142-9612(02)00248-X","article-title":"Toxic characteristics of methoxy poly(ethylene glycol)\/poly(epsilon-caprolactone) nanospheres: in vitro and in vivo studies in the normal mice","volume":"24","author":"Kim","year":"2003","journal-title":"Biomaterials"}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777651200046X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092777651200046X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:23:35Z","timestamp":1760523815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092777651200046X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":41,"alternative-id":["S092777651200046X"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2012.01.021","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymeric particles for the controlled release of human amylin","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2012.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}